Real-life treatment effect of biologic drugs in CRSwNP, Collection of clinical datas Nationwide in REDcap from both upper and lower airways, Combined treatment of surgey and biologic drugs versus biologic alone. Importance of pathology and inflammation, Importance of smell dysfunction, the neurological explantion, and the change during smell training. Cell growth in bench of nasal polyp tissue and invitro application of biologic drugs during growth, leading to information of the the in vitro differences between the different drugs. Sleep apnoe and DISE surgery, effect and posibilities.
Researchers
- Professor Vibeke Backer, MD DMSci, Pulmonologist, Rigshospitalet, UCPH and IKM
- Professor Christian von Buchwald, MD DMSci, ENT surgeon, Rigshospitalet, UCPH, IKM
- Ass professor Kasper Aanæs, MD PhD, UCPH, IKM
- Ass professor Eva K Kiaer, MD PhD, UCPH, MD
Phd Fellows
Ditte G Mogensen Master nursing, Christiane Haase Master nursing, Anne-Sophie Homøe MD, Jens Tidemandsen MD, Christian K Pedersen MD
Associated department
Department of Pathology, Department of clinical physiology
Funding
CAG - Chr von Buchwald
FEFFnonFESS - Vibeke Backer
Visiting scientists
- Professor Philippe Gevaert, Ghent, Belgium
- Professor Peter Hellings, Leuven, Belgium
- Professor Claus Bachert, Germany
- Professor T Hummel, Dresden, Germany
- Professor Peter Gibson, NewCastle, NSW Australia
- Professor Ian Pavord, Oxford, UK
Projects
- FESSnonFESS: CRSwNP surgery and biologics versus biologics
- Tornado: CRSwNP - head to head of two difrent biologic drugs
- Smell dysfunction in long COVID patients – RCT smell training versus placebo
- Adrenal dysfunction in patients with CRS and asthma a study of adrenal insufficiency and osteoporose
- Pulmonary dysfunction in patients with CRSwNP and possible change after treatment with biologic drugs.
- Low level of physical activity in patients with CRSwNP and effect of biologic treatment